We provide you with 20 years of free, institutional-grade data for SGEN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SGEN. Explore the full financial landscape of SGEN stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| HIMES VAUGHN B | Sale | -8,785 | $213.31 | $1,873,928 | 2023-11-13 |
| Epstein David R | Sale | -10,620 | $213.01 | $2,262,166 | 2023-11-13 |
| DANSEY ROGER D | Sale | -71 | $206.5 | $14,662 | 2023-09-22 |
| DANSEY ROGER D | Grant, award...etc | 4,980 | 2023-09-22 | ||
| HIMES VAUGHN B | Sale | -80 | $206.5 | $16,520 | 2023-09-22 |
| LIU JEAN I | Sale | -64 | $206.5 | $13,216 | 2023-09-22 |
| ROMP CHARLES R | Sale | -45 | $206.5 | $9,293 | 2023-09-22 |
| SIMPSON TODD E | Sale | -80 | $206.5 | $16,520 | 2023-09-22 |
| HIMES VAUGHN B | Sale | -8,785 | $205.76 | $1,807,602 | 2023-09-08 |
| HIMES VAUGHN B | Derivatives Exercise | 8,785 | 2023-09-08 | ||
| LIU JEAN I | Sale | -1,893 | $206.97 | $391,786 | 2023-09-01 |
| ROMP CHARLES R | Sale | -555 | $206.97 | $114,866 | 2023-09-01 |
| SIMPSON TODD E | Sale | -2,122 | $206.97 | $439,182 | 2023-09-01 |
| HIMES VAUGHN B | Sale | -1,795 | $206.97 | $371,504 | 2023-09-01 |
| DANSEY ROGER D | Sale | -4,029 | $206.97 | $833,866 | 2023-09-01 |
| SIMPSON TODD E | Sale | -485 | $206 | $99,910 | 2023-08-30 |
| SIMPSON TODD E | Grant, award...etc | 1,225 | 2023-08-30 | ||
| DANSEY ROGER D | Sale | -1,016 | $206 | $209,296 | 2023-08-30 |
| DANSEY ROGER D | Grant, award...etc | 1,872 | 2023-08-30 | ||
| HIMES VAUGHN B | Sale | -371 | $206 | $76,426 | 2023-08-30 |
| HIMES VAUGHN B | Grant, award...etc | 937 | 2023-08-30 | ||
| ROMP CHARLES R | Sale | -438 | $206 | $90,228 | 2023-08-30 |
| ROMP CHARLES R | Grant, award...etc | 1,107 | 2023-08-30 | ||
| LIU JEAN I | Sale | -405 | $206 | $83,430 | 2023-08-30 |
| LIU JEAN I | Grant, award...etc | 1,022 | 2023-08-30 | ||
| WELCH DANIEL G | Sale | -1,610 | $209.08 | $336,619 | 2023-08-29 |
| WELCH DANIEL G | Sale | -3,315 | $209.16 | $693,365 | 2023-08-29 |
| WELCH DANIEL G | Derivatives Exercise | 1,812 | 2023-08-29 | ||
| Epstein David R | Grant, award...etc | 39,650 | 2023-08-17 | ||
| HIMES VAUGHN B | Grant, award...etc | 11,469 | 2023-08-17 | ||
| LIU JEAN I | Grant, award...etc | 13,107 | 2023-08-17 | ||
| ROMP CHARLES R | Grant, award...etc | 13,107 | 2023-08-17 | ||
| SIMPSON TODD E | Grant, award...etc | 14,746 | 2023-08-17 | ||
| DANSEY ROGER D | Grant, award...etc | 25,747 | 2023-08-17 | ||
| ROMP CHARLES R | Sale | -708 | $192.46 | $136,262 | 2023-07-05 |
| HIMES VAUGHN B | Sale | -16,215 | $195.29 | $3,166,571 | 2023-06-09 |
| HIMES VAUGHN B | Derivatives Exercise | 16,215 | 2023-06-09 | ||
| WELCH DANIEL G | Grant, award...etc | 2,044 | 2023-06-02 | ||
| GRYSKA DAVID W | Grant, award...etc | 2,044 | 2023-06-02 | ||
| BAKER BROS. ADVISORS LP | Grant, award...etc | 2,044 | 2023-06-02 | ||
| BAKER BROS. ADVISORS LP | Grant, award...etc | 2,044 | 2023-06-02 | ||
| LOVE TED W | Grant, award...etc | 2,044 | 2023-06-02 | ||
| Orwin John A | Grant, award...etc | 2,044 | 2023-06-02 | ||
| SWAIN SANDRA M | Grant, award...etc | 2,044 | 2023-06-02 | ||
| Simonian Nancy A | Grant, award...etc | 2,044 | 2023-06-02 | ||
| Seth Alpna | Grant, award...etc | 2,044 | 2023-06-02 | ||
| ROMP CHARLES R | Sale | -349 | $189.86 | $66,261 | 2023-05-18 |
| WELCH DANIEL G | Sale | -1,864 | $200.02 | $372,837 | 2023-05-16 |
| WELCH DANIEL G | Derivatives Exercise | 1,864 | 2023-05-16 | ||
| WELCH DANIEL G | Sale | -10,725 | $200.06 | $2,145,644 | 2023-05-03 |
| WELCH DANIEL G | Sale | -16,307 | $200.04 | $3,262,052 | 2023-05-03 |
| WELCH DANIEL G | Derivatives Exercise | 15,661 | 2023-05-03 | ||
| BAKER BROS. ADVISORS LP | Derivatives Exercise | 17,500 | 2023-05-03 | ||
| LIU JEAN I | Sale | -5,000 | $205.86 | $1,029,311 | 2023-04-19 |
| LIU JEAN I | Derivatives Exercise | 5,000 | 2023-04-19 | ||
| DANSEY ROGER D | Sale | -10,000 | $205.95 | $2,059,488 | 2023-04-19 |
| DANSEY ROGER D | Derivatives Exercise | 10,000 | 2023-04-19 | ||
| SIMPSON TODD E | Sale | -55,344 | $204.14 | $11,297,924 | 2023-04-12 |
| SIMPSON TODD E | Derivatives Exercise | 55,344 | 2023-04-12 | ||
| DANSEY ROGER D | Sale | -333 | $205.86 | $68,550 | 2023-04-07 |
| DANSEY ROGER D | Grant, award...etc | 609 | 2023-04-07 | ||
| ROMP CHARLES R | Sale | -133 | $205.86 | $27,379 | 2023-04-07 |
| ROMP CHARLES R | Grant, award...etc | 348 | 2023-04-07 | ||
| HIMES VAUGHN B | Sale | -243 | $205.86 | $50,023 | 2023-04-07 |
| HIMES VAUGHN B | Grant, award...etc | 609 | 2023-04-07 | ||
| LIU JEAN I | Sale | -174 | $205.86 | $35,819 | 2023-04-07 |
| LIU JEAN I | Grant, award...etc | 435 | 2023-04-07 | ||
| SIMPSON TODD E | Sale | -243 | $205.86 | $50,023 | 2023-04-07 |
| SIMPSON TODD E | Grant, award...etc | 609 | 2023-04-07 | ||
| WELCH DANIEL G | Sale | -10,725 | $200.45 | $2,149,826 | 2023-04-05 |
| WELCH DANIEL G | Sale | -20,275 | $200.11 | $4,057,230 | 2023-04-05 |
| WELCH DANIEL G | Derivatives Exercise | 17,525 | 2023-04-05 | ||
| LIU JEAN I | Grant, award...etc | 1,389 | 2023-04-04 | ||
| HIMES VAUGHN B | Grant, award...etc | 1,214 | 2023-04-04 | ||
| DANSEY ROGER D | Grant, award...etc | 2,260 | 2023-04-04 | ||
| ROMP CHARLES R | Grant, award...etc | 1,294 | 2023-04-04 | ||
| SIMPSON TODD E | Grant, award...etc | 1,395 | 2023-04-04 | ||
| LIU JEAN I | Sale | -5,000 | $199.9 | $999,500 | 2023-03-17 |
| LIU JEAN I | Derivatives Exercise | 5,000 | 2023-03-17 | ||
| WELCH DANIEL G | Sale | -1,246 | $200.05 | $249,262 | 2023-03-17 |
| WELCH DANIEL G | Sale | -2,357 | $200.05 | $471,518 | 2023-03-17 |
| WELCH DANIEL G | Derivatives Exercise | 2,037 | 2023-03-17 | ||
| DANSEY ROGER D | Sale | -10,000 | $199.81 | $1,998,115 | 2023-03-17 |
| DANSEY ROGER D | Derivatives Exercise | 10,000 | 2023-03-17 | ||
| WELCH DANIEL G | Sale | -9,479 | $200.2 | $1,897,696 | 2023-03-16 |
| WELCH DANIEL G | Sale | -17,918 | $202.36 | $3,625,886 | 2023-03-16 |
| WELCH DANIEL G | Derivatives Exercise | 15,488 | 2023-03-16 | ||
| SIMPSON TODD E | Sale | -42,793 | $175.89 | $7,526,861 | 2023-03-10 |
| SIMPSON TODD E | Derivatives Exercise | 42,793 | 2023-03-10 | ||
| HIMES VAUGHN B | Sale | -16,215 | $177.07 | $2,871,190 | 2023-03-03 |
| HIMES VAUGHN B | Derivatives Exercise | 16,215 | 2023-03-03 | ||
| SIMPSON TODD E | Sale | -20,000 | $182.53 | $3,650,600 | 2023-02-28 |
| SIMPSON TODD E | Sale | -39,946 | $160 | $6,391,400 | 2023-02-21 |
| SIMPSON TODD E | Derivatives Exercise | 39,946 | 2023-02-21 | ||
| LIU JEAN I | Sale | -5,000 | $155 | $775,000 | 2023-02-21 |
| LIU JEAN I | Derivatives Exercise | 5,000 | 2023-02-21 | ||
| DANSEY ROGER D | Sale | -10,000 | $138.62 | $1,386,200 | 2023-02-17 |
| DANSEY ROGER D | Derivatives Exercise | 10,000 | 2023-02-17 | ||
| GRYSKA DAVID W | Derivatives Exercise | 8,750 | 2023-02-15 | ||
| DANSEY ROGER D | Sale | -783 | $138.52 | $108,461 | 2023-02-03 |
| DANSEY ROGER D | Sale | -10,000 | $135 | $1,350,000 | 2023-01-26 |
| DANSEY ROGER D | Derivatives Exercise | 10,000 | 2023-01-26 | ||
| LIU JEAN I | Sale | -5,000 | $135.03 | $675,134 | 2023-01-26 |
| LIU JEAN I | Derivatives Exercise | 5,000 | 2023-01-26 | ||
| LIU JEAN I | Sale | -578 | $130.71 | $75,548 | 2023-01-19 |
| DANSEY ROGER D | Sale | -10,000 | $135 | $1,350,000 | 2023-01-06 |
| DANSEY ROGER D | Derivatives Exercise | 10,000 | 2023-01-06 | ||
| LIU JEAN I | Sale | -5,000 | $135 | $675,000 | 2023-01-06 |
| LIU JEAN I | Derivatives Exercise | 5,000 | 2023-01-06 | ||
| ROMP CHARLES R | Sale | -1,129 | $127.63 | $144,094 | 2022-12-21 |
| DANSEY ROGER D | Sale | -10,000 | $135 | $1,350,000 | 2022-12-16 |
| DANSEY ROGER D | Derivatives Exercise | 10,000 | 2022-12-16 | ||
| Simonian Nancy A | Derivatives Exercise | 8,750 | 2022-12-14 |
The information provided in this report about SGEN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Seagen Inc(NASDAQ:SGEN) 
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADC...
Website: http://www.seattlegenetics.com
Founded: 1997
Full Time Employees: 1,605
Sector: Healthcare
Industry: Biotechnology